Investor Presentaiton
Unique Research & Investments team and process
Pioneering the royalty
market for 25+ years
Innovating new funding solutions,
including synthetic royalties
One Royalty Pharma team at the
center of every transaction
Long-tenured expert team
with deep scientific experience
Open business model: tailored
solutions and true partnerships
Proud of partnerships that grow
over multiple transactions
Platform built to scale
with the royalty market
Team and process growing to address the
large opportunity ahead
å
Exhaustive diligence process
sharpened over decades
Able to integrate and interpret a broad
and expanding information set
Leveraging big data through
Strategy & Analytics
Unique platform for clinical trial analysis
and market evaluation
ROYALTY PHARMA
49
49View entire presentation